Walleye Trading’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Sell
12,200
-72,000
-86% -$1.85M ﹤0.01% 2818
2025
Q4
$1.83M Buy
84,200
+33,800
+67% +$667K ﹤0.01% 1972
2025
Q3
$763K Buy
50,400
+11,800
+31% +$146K ﹤0.01% 2451
2025
Q2
$435K Buy
38,600
+3,400
+10% +$36.9K ﹤0.01% 2738
2025
Q1
$355K Hold
35,200
﹤0.01% 2747
2024
Q4
$416K Buy
35,200
+200
+0.6% +$2.37K ﹤0.01% 2747
2024
Q3
$404K Sell
35,000
-7,200
-17% -$82K ﹤0.01% 2646
2024
Q2
$446K Buy
+42,200
New +$462K ﹤0.01% 2574

Other funds holding ROIV

Walleye Trading's ROIV Position: Q1 2026 in Review

Walleye Trading opened a new position in Roivant Sciences (ROIV) in Q1 2026: 3,420 shares worth $94.7K. The stake represents ﹤0.01% of the portfolio and ranks #3478 among its holdings. This is a return to the name: Walleye Trading previously reported a position in ROIV as recently as Q4 2023.

Walleye Trading first reported a position in ROIV in Q4 2023 and has held it in 2 quarters since. The position peaked at $446K in Q4 2023. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Walleye Trading held 3,420 shares of Roivant Sciences worth $94.7K as of Q1 2026.
  • Roivant Sciences was a new Walleye Trading position in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3478 holding.
  • Walleye Trading first reported a position in Roivant Sciences in Q4 2023 and has held it in 2 quarters since.
  • Walleye Trading's Roivant Sciences position peaked at $446K in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.